Class information for:
Level 2: ENDOCRINE POLYPEPTIDE CANC//LHRH RECEPTOR//SECT EXPT MED

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
2982 2124 33.0 65%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)


ID, lev.
above		 Publications Label for level above
86 77386 REPRODUCTIVE BIOLOGY//FERTILITY AND STERILITY//HUMAN REPRODUCTION

Classes in level below (level 1)


ID, lev. below Publications Label for level below
9482 1083 AZALINE B//ANTIOVULATORY ACTIVITY//LHRH ANTAGONISTS
14625 692 LHRH RECEPTOR//AN 152//ENDOCRINE POLYPEPTIDE CANC
27080 196 ENDOCRINE POLYPEPTIDE CANC//GHRH ANTAGONISTS//GHRH ANTAGONIST
29412 153 EXPLORATORY DISCOVERY//CYCLIC IMINES//3 ACYLLACTAMS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ENDOCRINE POLYPEPTIDE CANC Address 129 63% 6% 131
2 LHRH RECEPTOR Author keyword 30 84% 1% 16
3 SECT EXPT MED Address 28 40% 3% 56
4 GHRH ANTAGONISTS Author keyword 23 86% 1% 12
5 GHRH ANTAGONIST Author keyword 22 81% 1% 13
6 AN 152 Author keyword 18 89% 0% 8
7 GH RH ANTAGONISTS Author keyword 18 89% 0% 8
8 LH RH ANTAGONIST Author keyword 15 68% 1% 13
9 LH RH RECEPTORS Author keyword 14 100% 0% 7
10 TARGETED CHEMOTHERAPY Author keyword 13 38% 1% 26

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 LHRH RECEPTOR 30 84% 1% 16 Search LHRH+RECEPTOR Search LHRH+RECEPTOR
2 GHRH ANTAGONISTS 23 86% 1% 12 Search GHRH+ANTAGONISTS Search GHRH+ANTAGONISTS
3 GHRH ANTAGONIST 22 81% 1% 13 Search GHRH+ANTAGONIST Search GHRH+ANTAGONIST
4 AN 152 18 89% 0% 8 Search AN+152 Search AN+152
5 GH RH ANTAGONISTS 18 89% 0% 8 Search GH+RH+ANTAGONISTS Search GH+RH+ANTAGONISTS
6 LH RH ANTAGONIST 15 68% 1% 13 Search LH+RH+ANTAGONIST Search LH+RH+ANTAGONIST
7 LH RH RECEPTORS 14 100% 0% 7 Search LH+RH+RECEPTORS Search LH+RH+RECEPTORS
8 TARGETED CHEMOTHERAPY 13 38% 1% 26 Search TARGETED+CHEMOTHERAPY Search TARGETED+CHEMOTHERAPY
9 GROWTH HORMONE RELEASING HORMONE ANTAGONIST 12 86% 0% 6 Search GROWTH+HORMONE+RELEASING+HORMONE+ANTAGONIST Search GROWTH+HORMONE+RELEASING+HORMONE+ANTAGONIST
10 TARGETED CANCER CHEMOTHERAPY 12 86% 0% 6 Search TARGETED+CANCER+CHEMOTHERAPY Search TARGETED+CANCER+CHEMOTHERAPY

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 GH RH 69 93% 1% 26
2 ANTAGONIST SB 75 53 95% 1% 18
3 500 1000 TIMES 50 88% 1% 23
4 HUMAN ENDOMETRIAL 33 49% 2% 49
5 IN VIVO PROLIFERATION 32 62% 2% 33
6 LHRH ANTAGONISTS 30 100% 1% 12
7 MOUSE MAMMARY CANCERS 30 100% 1% 12
8 ANTAGONISTIC ANALOGS 27 92% 1% 11
9 RESISTANCE 1 MDR 1 SYSTEM 26 100% 1% 11
10 SUBSTITUTED INDOLE 5 CARBOXAMIDES 25 77% 1% 17

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Targeting of cytotoxic luteinizing hormone-releasing hormone analogs to breast, ovarian, endometrial, and prostate cancers 2005 70 79 85%
New approaches to the therapy of various tumors based on peptide analogues 2008 47 63 70%
GnRH Receptors in Cancer: From Cell Biology to Novel Targeted Therapeutic Strategies 2012 16 265 51%
Gonadotropin-releasing hormone receptors as molecular therapeutic targets in prostate cancer: Current options and emerging strategies 2013 12 236 49%
Gonadotropin-releasing hormone: GnRH receptor signaling in extrapituitary tissues 2008 48 145 52%
THE USE OF LUTEINIZING-HORMONE-RELEASING HORMONE AGONISTS AND ANTAGONISTS IN GYNECOLOGICAL CANCERS 1994 138 80 74%
GONADOTROPIN-RELEASING-HORMONE ANALOG DESIGN - STRUCTURE-FUNCTION STUDIES TOWARD THE DEVELOPMENT OF AGONISTS AND ANTAGONISTS - RATIONALE AND PERSPECTIVE 1986 412 64 63%
Receptor-mediated tumor targeting based on peptide hormones 2010 32 87 37%
Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer 2008 32 74 64%
Use of Analogs of Peptide Hormones Conjugated to Cytotoxic Radicals for Chemotherapy Targeted to Receptors on Tumors 2011 22 99 53%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ENDOCRINE POLYPEPTIDE CANC 129 63% 6.2% 131
2 SECT EXPT MED 28 40% 2.6% 56
3 EXPLORATORY DISCOVERY 11 69% 0.4% 9
4 S FLORIDA VET AFFAIRS FDN EDUC 8 75% 0.3% 6
5 POLYPEPTIDE CANC 6 80% 0.2% 4
6 GEN HOSP OBERNDORF 5 63% 0.2% 5
7 ANALYT CHEM BIOPOLYMER STRUCT ANAL 5 27% 0.7% 15
8 BIOMED PHYS ENGN 3 42% 0.2% 5
9 HEMATOL ONCOL ENDOCRINOL 2 33% 0.3% 6
10 MULTIDISCIPLINARY GYNECOL ONCOL 2 67% 0.1% 2

Related classes at same level (level 2)


Rank Relatedness score Related classes
1 0.0000030737 HYPOTHALAMIC HAMARTOMA//GELASTIC SEIZURES//GELASTIC SEIZURE
2 0.0000023425 KISSPEPTIN//GPR54//NEUROENDOCRINOLOGY
3 0.0000019371 TESTIS//SERTOLI CELLS//SPERMATOGENESIS
4 0.0000017073 BENIGN PROSTATIC HYPERPLASIA//PROSTATE CANCER//PROSTATE
5 0.0000011472 SOMATOSTATIN//HYPERPOLARIZED C 13//SOMATOSTATIN RECEPTORS
6 0.0000011404 INHIBIN//CORPUS LUTEUM//ACTIVIN
7 0.0000010224 SMALL CELL LUNG CANCER//BOMBESIN//GASTRIN RELEASING PEPTIDE
8 0.0000009764 17 BETA AMINOESTROGENS//PROLAME//PENTOLAME
9 0.0000009689 BOAR TAINT//ANDROSTENONE//SKATOLE
10 0.0000009307 USA HCG REFERENCE SERV//FSH RECEPTOR//HYPERGLYCOSYLATED HCG